Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, April 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 244 articles:
HTML format


 

Single Articles

  1. L MACEDO AC, Luz Moretti Borba CD, Bavaresco DV, Colonetti T, et al
    Accuracy of mRNA HPV tests as a predictor of recurrence of precursor lesions and cervical cancer after conization: a systematic review and meta-analysis.
    Biomark Med. 2019 Mar 29. doi: 10.2217/bmm-2018-0373.
    Abstract    

    Abstract available

  2. ZHAO Q, Wang W, Cui J
    Melatonin enhances TNF-alpha-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis.
    Cancer Cell Int. 2019;19:58.
    Abstract    

    Abstract available

  3. GUERRA RODRIGUEZ GM, Champion JD, Moreno Monsivais MG, Olivares Ornelas OA, et al
    Cervical Cancer Protective Behavioral Patterns Among Mexican Women Living With HPV.
    Hisp Health Care Int. 2019 Mar 28:1540415319830763.
    Abstract    

    Abstract available

  4. DONKOH ET, Agyemang-Yeboah F, Asmah RH, Wiredu EK, et al
    Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.
    Medicine (Baltimore). 2019;98:e14600.
    Abstract    

    Abstract available

  5. ZHAN YZ, Liu F, Zhang Y, Mo XY, et al
    [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2019;41:200-207.
    Abstract    

    Abstract available

  6. SHEN W, Xie XY, Liu MR, Wang LL, et al
    MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
    Eur Rev Med Pharmacol Sci. 2019;23:1957-1968.
    Abstract    

    Abstract available

  7. LV XJ, Tang Q, Tu YQ, Yan DD, et al
    Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/beta-catenin pathway and is a prognosis marker in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:1947-1956.
    Abstract    

    Abstract available

  8. FANG CY, Lee M, Feng Z, Tan Y, et al
    Community-Based Cervical Cancer Education: Changes in Knowledge and Beliefs Among Vietnamese American Women.
    J Community Health. 2019 Mar 26. pii: 10.1007/s10900-019-00645.
    Abstract    

    Abstract available

  9. OLAZA-MAGUINA AF, De la Cruz-Ramirez YM
    Barriers to the non-acceptance of cervical cancer screenings (pap smear test) in women of childbearing age in a rural area of Peru.
    Ecancermedicalscience. 2019;13:901.
    Abstract    

    Abstract available

  10. YABUNO A, Hasegawa K
    [.Minimally Invasive Surgery for Cervical Cancer].
    Gan To Kagaku Ryoho. 2019;46:230-235.
    Abstract    



  11. RIGAUD B, Klopp A, Vedam S, Venkatesan A, et al
    Deformable image registration for dose mapping between external beam radiotherapy and brachytherapy images of cervical cancer.
    Phys Med Biol. 2019 Mar 26. doi: 10.1088/1361-6560/ab1378.
    Abstract    

    Abstract available

  12. KIM K, Han HR
    Health Literacy and Breast and Cervical Cancer Screening Behaviors: Findings from the Behavioral Risk Factor Surveillance System.
    Nurs Res. 2019 Mar 25. doi: 10.1097/NNR.0000000000000346.
    Abstract    

    Abstract available

  13. DESAI F, Singh LS, Majachunglu G, Kamei H, et al
    Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs
    Asian Pac J Cancer Prev. 2019;20:917-923.
    Abstract    

    Abstract available

  14. PRABAWA IPY, Bhargah A, Liwang F, Tandio DA, et al
    Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer
    Asian Pac J Cancer Prev. 2019;20:863-868.
    Abstract    

    Abstract available

  15. ZHANG X, Zhao X, Li Y, Zhou Y, et al
    Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    J Cell Physiol. 2019 Mar 25. doi: 10.1002/jcp.28371.
    Abstract    

    Abstract available

  16. VALE DB, Sauvaget C, Murillo R, Muwonge R, et al
    Correlation of Cervical Cancer Mortality with Fertility, Access to Health Care and Socioeconomic Indicators.
    Rev Bras Ginecol Obstet. 2019 Mar 25. doi: 10.1055/s-0039-1683859.
    Abstract    

    Abstract available

  17. RIZZUTO I, MacNab W, Nicholson R, Nalam M, et al
    Less radical surgery for women with early stage cervical cancer: Our experience on radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy.
    Gynecol Oncol Rep. 2019;28:65-67.
    Abstract    

    Abstract available

  18. KATIYAR V, Araujo T, Majeed N, Ree N, et al
    Multiple recurrences from cervical cancer presenting as skin metastasis of different morphologies.
    Gynecol Oncol Rep. 2019;28:61-64.
    Abstract    

    Abstract available

  19. FROHLICH G, Vizkeleti J, Nguyen AN, Major T, et al
    Comparative analysis of image-guided adaptive interstitial brachytherapy and intensity-modulated arc therapy versus conventional treatment techniques in cervical cancer using biological dose summation.
    J Contemp Brachytherapy. 2019;11:69-75.
    Abstract    

    Abstract available

  20. LIU B, Ma WL, Zhang GW, Sun Z, et al
    Changes in magnetic resonance T2-weighted imaging signal intensity correlate with concurrent chemoradiotherapy response in cervical cancer.
    J Contemp Brachytherapy. 2019;11:41-47.
    Abstract    

    Abstract available

  21. MURAKAMI N, Shima S, Kashihara T, Tselis N, et al
    Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.
    J Contemp Brachytherapy. 2019;11:1-7.
    Abstract    

    Abstract available

  22. ZHANG Y, Sun B, Zhao L, Liu Z, et al
    Upregulation of microRNA-148a inhibits proliferation, invasion and migration while promoting apoptosis of cervical cancer cells by downregulating RRS1.
    Biosci Rep. 2019 Mar 25. pii: BSR20181815. doi: 10.1042/BSR20181815.
    Abstract    

    Abstract available

  23. BALAYA V, Mathevet P, Magaud L, Delomenie M, et al
    Predictive factors of severe perioperative morbidity of radical hysterectomy with lymphadenectomy in early-stage cervical cancer: A French prospective multicentric cohort of 248 patients.
    Eur J Surg Oncol. 2019;45:650-658.
    Abstract    

    Abstract available

  24. FRAYLE H, Gori S, Rizzi M, Graziani BN, et al
    HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.
    BMC Womens Health. 2019;19:47.
    Abstract    

    Abstract available

  25. ZAFAR A, Singh S, Ahmad S, Khan S, et al
    Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
    Bioorg Chem. 2019;87:276-290.
    Abstract    

    Abstract available

  26. ZHU Y, Wu Y, Yang L, Dou X, et al
    LncRNA ATB promotes proliferation and invasion of cervical cancer cells via regulating miR-144/ITGA6 axis.
    Exp Physiol. 2019 Mar 25. doi: 10.1113/EP087656.
    Abstract    

    Abstract available

  27. RUIZ-MAZA JC, Soto-Azpilcueta RA, Sanchez-Salvatierra J, Torres-Prado Y, et al
    Cytological screening for cervical cancer and associated factors in the penitentiary population of Peru.
    Rev Esp Sanid Penit. 2018;20:103-110.
    Abstract    

    Abstract available

  28. KURT G, Akyuz A
    Evaluating the Effectiveness of Interventions on Increasing Participation in Cervical Cancer Screening.
    J Nurs Res. 2019 Mar 21. doi: 10.1097/jnr.0000000000000317.
    Abstract    

    Abstract available

  29. MOSCICKI AB, Flowers L, Huchko MJ, Long ME, et al
    Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    J Low Genit Tract Dis. 2019;23:87-101.
    Abstract    

    Abstract available

  30. YIN S, Zhang Q, Wang Y, Li S, et al
    MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.
    Exp Ther Med. 2019;17:2837-2846.
    Abstract    

    Abstract available

  31. CHE Y, Li Y, Zheng F, Zou K, et al
    TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
    Cancer Lett. 2019;452:1-13.
    Abstract    

    Abstract available

  32. DRAGHINI L, Costantini S, Vicenzi L, Italiani M, et al
    Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Radiol Med. 2019 Mar 23. pii: 10.1007/s11547-019-01023.
    Abstract    

    Abstract available

  33. WANG Z, Wang Q, Zhao J, Gong L, et al
    Altered diversity and composition of the gut microbiome in patients with cervical cancer.
    AMB Express. 2019;9:40.
    Abstract    

    Abstract available

  34. BALCACER P, Shergill A, Litkouhi B
    MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls.
    Abdom Radiol (NY). 2019 Mar 22. pii: 10.1007/s00261-019-01984.
    Abstract    

    Abstract available

  35. PEZZOTTO SM, Nieto CS, Baroni MA, Iwanow P, et al
    [Study about skin cancer screening in comparison with breast and cervix cancer screening in a female sample from Concordia, Argentina.]
    Rev Fac Cien Med Univ Nac Cordoba. 2019;76:11-18.
    Abstract    

    Abstract available

  36. KLEIN C, Gonzalez D, Samwel K, Kahesa C, et al
    Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions.
    MBio. 2019;10.
    Abstract    

    Abstract available

  37. RAMEZANI A, Aghakhani A, Soleymani S, Bavand A, et al
    Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women.
    BMC Infect Dis. 2019;19:142.
    Abstract    

    Abstract available

  38. JOOB B, Wiwanitkti V
    Re: HPV vaccination for penile cancer eradication: cost effectiveness view.
    Int Braz J Urol. 2019;45:199-200.
    Abstract    



  39. MOGA MA, Balan A, Anastasiu CV, Dimienescu OG, et al
    An Overview on the Anticancer Activity of Azadirachta indica (Neem) in Gynecological Cancers.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  40. BUANG SN, Ja'afar S, Pathmanathan I, Saint V, et al
    Human papillomavirus immunisation of adolescent girls: improving coverage through multisectoral collaboration in Malaysia.
    BMJ. 2018;363:k4602.
    Abstract    



  41. ZHANG Z, Niu N, Gao X, Han F, et al
    A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy.
    Colloids Surf B Biointerfaces. 2019;173:335-345.
    Abstract    

    Abstract available

  42. POWELL N, Hibbitts S, Evans M
    Gender neutral vaccination against HPV.
    BMJ. 2018;362:k3837.
    Abstract    



  43. HAMANO H, Mitsui M, Zamami Y, Takechi K, et al
    Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.
    Support Care Cancer. 2019;27:849-856.
    Abstract    

    Abstract available

  44. XIANG H, Zhou J, Peng H, Dong W, et al
    [Association of EGFR gene G719S and T790M mutations with cervical cancer].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019;36:376-379.
    Abstract    

    Abstract available

  45. ZHANG Q, Zhang Y, Wang Y
    GHET1 acts as a prognostic indicator and functions an oncogenic lncRNA in cervical cancer.
    Biosci Rep. 2019 Apr 4. pii: BSR20182506. doi: 10.1042/BSR20182506.
    Abstract    

    Abstract available

  46. HEAD KJ, Johnson NL, Scott SF, Zimet GD, et al
    Communicating Cervical Cancer Screening Results in Light of New Guidelines: Clinical Practices at Federally Qualified Health Centers.
    Health Commun. 2019 Apr 4:1-7. doi: 10.1080/10410236.2019.1593079.
    Abstract    

    Abstract available

  47. RONG G, Zhang M, Xia W, Li D, et al
    Plasma CADM1 promoter hypermethylation and D-dimer as novel metastasis predictors of cervical cancer.
    J Obstet Gynaecol Res. 2019 Apr 3. doi: 10.1111/jog.13966.
    Abstract    

    Abstract available

  48. SUN JJ, Li HL, Guo SJ, Ma H, et al
    The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
    Dis Markers. 2019;2019:5380197.
    Abstract    

    Abstract available

  49. PENG LN, Shi WT, Feng HR, Wei CY, et al
    Effect of miR-301a/PTEN pathway on the proliferation and apoptosis of cervical cancer.
    Innate Immun. 2019 Apr 3:1753425919840702. doi: 10.1177/1753425919840702.
    Abstract    

    Abstract available

  50. CHUNG HC, Ros W, Delord JP, Perets R, et al
    Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.
    J Clin Oncol. 2019 Apr 3:JCO1801265. doi: 10.1200/JCO.18.01265.
    Abstract    

    Abstract available

  51. ZHOU Q, Jiang X, Yan W, Dou X, et al
    Transgelin 2 overexpression inhibits cervical cancer cell invasion and migration.
    Mol Med Rep. 2019 Apr 3. doi: 10.3892/mmr.2019.10116.
    Abstract    

    Abstract available

  52. QIAN L, Su W, Wang Y, Dang M, et al
    Synthesis and characterization of gold nanoparticles from aqueous leaf extract of Alternanthera sessilis and its anticancer activity on cervical cancer cells (HeLa).
    Artif Cells Nanomed Biotechnol. 2019;47:1173-1180.
    Abstract    

    Abstract available

  53. GAI J, Wang X, Meng Y, Xu Z, et al
    Clinicopathological factors influencing the prognosis of cervical cancer.
    J BUON. 2019;24:291-295.
    Abstract    

    Abstract available


  54. Correction: Automatic classification of cervical cancer from cytological images by using convolutional neural network.
    Biosci Rep. 2019;39.
    Abstract    



  55. ZHENG M, Hou L, Ma Y, Zhou L, et al
    Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
    Mol Cancer. 2019;18:76.
    Abstract    

    Abstract available

  56. BROUSSEAU EC, Ahn S, Matteson KA
    Cervical Cancer Screening Access, Outcomes, and Prevalence of Dysplasia in Correctional Facilities: A Systematic Review.
    J Womens Health (Larchmt). 2019 Apr 2. doi: 10.1089/jwh.2018.7440.
    Abstract    

    Abstract available

  57. RAHMAN R, Clark MD, Collins Z, Traore F, et al
    Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review.
    Glob Health Action. 2019;12:1587894.
    Abstract    

    Abstract available

  58. SANCHEZ M, Castro-Eguiluz D, Luvian-Morales J, Jimenez-Lima R, et al
    Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy.
    J Hum Nutr Diet. 2019 Apr 1. doi: 10.1111/jhn.12649.
    Abstract    

    Abstract available

  59. MANDAL P, Saha SS, Sen S, Bhattacharya A, et al
    Cervical cancer subtypes harbouring integrated and/or episomal HPV16 portray distinct molecular phenotypes based on transcriptome profiling of mRNAs and miRNAs.
    Cell Death Discov. 2019;5:81.
    Abstract    

    Abstract available

  60. FIRMINO-MACHADO J, Varela S, Mendes R, Moreira A, et al
    A 3-step intervention to improve adherence to cervical cancer screening: The SCAN randomized controlled trial.
    Prev Med. 2019 Mar 29. pii: S0091-7435(19)30101.
    Abstract    

    Abstract available

  61. FENG Y, Ma J, Fan H, Liu M, et al
    TNF-alpha-induced lncRNA LOC105374902 promotes the malignant behavior of cervical cancer cells by acting as a sponge of miR-1285-3p.
    Biochem Biophys Res Commun. 2019 Mar 29. pii: S0006-291X(19)30468.
    Abstract    

    Abstract available

  62. SAGE SK, Hawkins-Taylor C, Crockett RA Sr, Balls-Berry JE, et al
    "Girl, just pray ...": Factors That Influence Breast and Cervical Cancer Screening Among Black Women in Rochester, MN.
    J Natl Med Assoc. 2019 Mar 29. pii: S0027-9684(18)30295.
    Abstract    

    Abstract available

  63. BAKAI OA, Golovko TS, Ganich AV, Gavriluk ON, et al
    Radiation research to determine local tumor invasion in patients with cervical cancer.
    Exp Oncol. 2019;41:57-60.
    Abstract    

    Abstract available

  64. YUAN LY, Zhou M, Lv H, Qin X, et al
    Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4.
    J Cell Physiol. 2019 Apr 1. doi: 10.1002/jcp.28538.
    Abstract    

    Abstract available

  65. KURIA M, Gitau S, Warfa K
    Cervical cancer with bilateral ovarian metastases: case report and review of literature.
    BJR Case Rep. 2018;4:20180047.
    Abstract    

    Abstract available

  66. QIU G, Yu Y, Wang Y, Wang X, et al
    The significance of probiotics in preventing radiotherapy-induced diarrhea in patients with cervical cancer: A systematic review and meta-analysis.
    Int J Surg. 2019;65:61-69.
    Abstract    

    Abstract available

  67. LI J, Chen Q, Deng Z, Chen X, et al
    KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.
    Life Sci. 2019 Mar 27. pii: S0024-3205(19)30229.
    Abstract    

    Abstract available

  68. LI K, Sun H, Guo Q
    Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Eur J Radiol. 2019;113:153-157.
    Abstract    

    Abstract available

  69. AMEMIYA T, Shibata K, Du Y, Nakata S, et al
    Modeling studies of heterogeneities in glycolytic oscillations in HeLa cervical cancer cells.
    Chaos. 2019;29:033132.
    Abstract    

    Abstract available

  70. ZHAI L, Yadav R, Kunda NK, Anderson D, et al
    Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
    Antiviral Res. 2019 Mar 26. pii: S0166-3542(19)30077.
    Abstract    

    Abstract available

  71. OHKAWA M, Arai W, Takahashi Y, Maki R, et al
    [Surgical Treatment for Pneumopyothorax Secondary to Pancreatic Fistula].
    Kyobu Geka. 2019;72:209-212.
    Abstract    

    Abstract available

  72. GADDUCCI A, Guerrieri ME, Cosio S
    Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.
    Crit Rev Oncol Hematol. 2019;135:103-114.
    Abstract    

    Abstract available

  73. XU J, Liu H, Yang Y, Wang X, et al
    Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.
    MBio. 2019;10.
    Abstract    

    Abstract available

  74. CHEN H, Wang H, Liu J, Cheng Q, et al
    Association of Base Excision Repair Gene hOGG1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population.
    Genet Test Mol Biomarkers. 2019;23:138-144.
    Abstract    

    Abstract available

  75. PRIYANGA S, Khamrang T, Velusamy M, Karthi S, et al
    Coordination geometry-induced optical imaging of l-cysteine in cancer cells using imidazopyridine-based copper(ii) complexes.
    Dalton Trans. 2019;48:1489-1503.
    Abstract    

    Abstract available

  76. ARBYN M, Smith SB, Temin S, Sultana F, et al
    Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
    BMJ. 2018;363:k4823.
    Abstract    

    Abstract available

  77. IACOBUCCI G
    Cervical screening: GP leaders slam Capita over failure to send up to 48 500 letters.
    BMJ. 2018;363:k4832.
    Abstract    



  78. LEE MK, Shin G
    A mobile video intervention for women's health of North Korean defectors.
    Public Health Nurs. 2018;35:558-562.
    Abstract    

    Abstract available

  79. RESTIVO V, Costantino C, Marras A, Napoli G, et al
    Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women.
    Int J Environ Res Public Health. 2018;15.
    Abstract    

    Abstract available

  80. JORGENSEN L, Gotzsche PC, Jefferson T
    The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias.
    BMJ Evid Based Med. 2018;23:165-168.
    Abstract    



  81. XU H, Egger S, Velentzis LS, O'Connell DL, et al
    Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia.
    Cancer Epidemiol. 2018;55:162-169.
    Abstract    

    Abstract available

  82. ROCHA VSO, Malfacini SDS, Gomes AM, Rocha CRMD, et al
    External Quality Monitoring of the Cervical Cytopathological Exams in the Rio de Janeiro City.
    Rev Bras Ginecol Obstet. 2018;40:338-346.
    Abstract    

    Abstract available

  83. SHEN C, Gonzalez Y, Klages P, Qin N, et al
    Intelligent inverse treatment planning via deep reinforcement learning, a proof-of-principle study in high dose-rate brachytherapy for cervical cancer.
    Phys Med Biol. 2019 Apr 12. doi: 10.1088/1361-6560.
    Abstract    

    Abstract available

  84. UEDA Y, Kawana K, Yanaihara N, Banno K, et al
    Development and evaluation of a cervical cancer screening system in Cambodia: A collaborative project of the Cambodian Society of Gynecology and Obstetrics and Japan Society of Obstetrics and Gynecology.
    J Obstet Gynaecol Res. 2019 Apr 11. doi: 10.1111/jog.13968.
    Abstract    

    Abstract available

  85. ZHOU Y, Shu C, Huang Y
    Fibronectin promotes cervical cancer tumorigenesis through activating FAK signaling pathway.
    J Cell Biochem. 2019 Apr 11. doi: 10.1002/jcb.28282.
    Abstract    

    Abstract available

  86. FANG L, Liu M, Cai L
    [Hederagenin inhibits proliferation and promotes apoptosis of cervical cancer CaSki cells by blocking STAT3 pathway].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019;35:140-145.
    Abstract    

    Abstract available

  87. WANG H, Wang J, Liu H, Wang X, et al
    [TGF-beta1 activates NOX4/ROS pathway to promote the invasion and migration of cervical cancer cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019;35:121-127.
    Abstract    

    Abstract available

  88. KHAN I, Nam M, Kwon M, Seo SS, et al
    LC/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics.
    Cancers (Basel). 2019;11.
    Abstract    

    Abstract available

  89. JIANG G
    Recent Developments of Nanoparticles In The Treatment Of Photodynamic Therapy For Cervical Cancer.
    Anticancer Agents Med Chem. 2019 Apr 11. pii: ACAMC-EPUB-98019.
    Abstract    

    Abstract available

  90. LIN AJ, Samson P, Zoberi J, Garcia-Ramirez J, et al
    Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
    Brachytherapy. 2019 Jan 14. pii: S1538-4721(18)30682.
    Abstract    

    Abstract available

  91. WONG FL, Miller JW
    Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program: Increasing Access to Screening.
    J Womens Health (Larchmt). 2019;28:427-431.
    Abstract    

    Abstract available

  92. LUO Q, Wang H, Li J
    Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Clin Lab. 2019;65.
    Abstract    

    Abstract available

  93. GEBREMARIAM A, Addissie A, Worku A, Hirpa S, et al
    Breast and cervical cancer patients' experience in Addis Ababa city, Ethiopia: a follow-up study protocol.
    BMJ Open. 2019;9:e027034.
    Abstract    

    Abstract available

  94. LEAVER CA, Yuan H, Wallen GR
    Apoptotic Activities of Sanguinaria canadensis: Primary Human Keratinocytes, C-33A, and Human Papillomavirus HeLa Cervical Cancer Lines.
    Integr Med (Encinitas). 2018;17:32-37.
    Abstract    

    Abstract available

  95. ZHANG Y, Jia LG, Wang P, Li J, et al
    The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines.
    Eur Rev Med Pharmacol Sci. 2019;23:2380-2390.
    Abstract    

    Abstract available

  96. GUO LY, Qin CF, Zou HX, Song MY, et al
    LncRNA AB073614 promotes the proliferation and inhibits apoptosis of cervical cancer cells by repressing RBM5.
    Eur Rev Med Pharmacol Sci. 2019;23:2374-2379.
    Abstract    

    Abstract available

  97. DEGENNARO V JR, Shafer M, Kelly M, Cornely JR, et al
    Cervical cancer treatment in Haiti: A vertically-integrated model for low-resource settings.
    Gynecol Oncol Rep. 2019;28:71-75.
    Abstract    

    Abstract available

  98. ZHONG S, Zhang Y, Yin X, Di W, et al
    CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer.
    Onco Targets Ther. 2019;12:2137-2147.
    Abstract    

    Abstract available

  99. LI P, Xu M, Cai H, Thapa N, et al
    The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer.
    Biosci Rep. 2019 Apr 8. pii: BSR20181016. doi: 10.1042/BSR20181016.
    Abstract    

    Abstract available

  100. DESHPANDE R, Raina P, Shinde K, Mansara P, et al
    Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer.
    Prostaglandins Other Lipid Mediat. 2019 Apr 5. pii: S1098-8823(18)30109.
    Abstract    

    Abstract available

  101. WALI LM, Helal AM, Darwesh RM, Attar MA, et al
    A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate brachytherapy (HDR) in localized cervical cancer radiotherapy.
    J Xray Sci Technol. 2019 Mar 30. pii: XST180468. doi: 10.3233/XST-180468.
    Abstract    

    Abstract available

  102. RUIZ-LOPEZ T, Sen S, Jakobsen E, Trope A, et al
    FightHPV: Design and Evaluation of a Mobile Game to Raise Awareness About Human Papillomavirus and Nudge People to Take Action Against Cervical Cancer.
    JMIR Serious Games. 2019;7:e8540.
    Abstract    

    Abstract available

  103. CHAUDHARY M, Kumar N, Baldi A, Chandra R, et al
    4-Bromo 4'-chloro pyrazoline analog of curcumin augmented anticancer activity against Human cervical cancer, HeLa cells: In-silico guided analysis, synthesis and in-vitro cytotoxicity.
    J Biomol Struct Dyn. 2019 Apr 8:1-40. doi: 10.1080/07391102.2019.1604266.
    Abstract    

    Abstract available

  104. HOFSJO A, Bohm-Starke N, Bergmark K, Masironi B, et al
    Sex steroid hormone receptor expression in the vaginal wall in cervical cancer survivors after radiotherapy.
    Acta Oncol. 2019 Apr 8:1-9. doi: 10.1080/0284186X.2019.1598574.
    Abstract    

    Abstract available

  105. PIONTEK T, Harmel C, Pawlita M, Carow K, et al
    Post-treatment human papillomavirus antibody kinetics in cervical cancer patients.
    Philos Trans R Soc Lond B Biol Sci. 2019;374:20180295.
    Abstract    

    Abstract available

  106. MIYAKE K, Murata T, Murakami T, Zhao M, et al
    Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
    Arch Gynecol Obstet. 2019 Apr 5. pii: 10.1007/s00404-019-05147.
    Abstract    

    Abstract available

  107. KUBOTA Y, Ohno T, Kawashima M, Murata K, et al
    Development of a Vaginal Immobilization Device: A Treatment-planning Study of Carbon-ion Radiotherapy and Intensity-modulated Radiation Therapy for Uterine Cervical Cancer.
    Anticancer Res. 2019;39:1915-1921.
    Abstract    

    Abstract available

  108. SCHOLL S, Popovic M, de la Rochefordiere A, Girard E, et al
    Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
    EBioMedicine. 2019 Apr 2. pii: S2352-3964(19)30214.
    Abstract    

    Abstract available

  109. ABE-DOI M, Murayama R, Yabunaka K, Tanabe H, et al
    Ultrasonographic assessment of an induration caused by extravasation of a nonvesicant anticancer drug: A case report.
    Medicine (Baltimore). 2019;98:e15043.
    Abstract    

    Abstract available

  110. LAN J, Wu X, Luo L, Liu J, et al
    Fluorescent Ag clusters conjugated with anterior gradient-2 antigen aptamer for specific detection of cancer cells.
    Talanta. 2019;197:86-91.
    Abstract    

    Abstract available

  111. REBOLJ M, Rimmer J, Denton K, Tidy J, et al
    Primary cervical screening with high risk human papillomavirus testing: observational study.
    BMJ. 2019;364:l240.
    Abstract    

    Abstract available

  112. ROOPNGAM PE
    Increased Response of Human T-Lymphocytes by Dendritic Cells Pulsed with HPV16E7 and Pleurotus sajor-caju-beta-glucan (PBG).
    Iran J Immunol. 2018;15:246-255.
    Abstract    

    Abstract available

  113. KIM MA, Han GH, Kim JH, Seo K, et al
    Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview.
    J Korean Med Sci. 2018;33:e331.
    Abstract    

    Abstract available

  114. JENDOUBI-FERCHICHI M, Satouri L, Ghoul F, Malek-Mellouli M, et al
    Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions
    Asian Pac J Cancer Prev. 2018;19:3361-3366.
    Abstract    

    Abstract available

  115. JAHAGIRDAR D, Gore CR, Patel H, Maria K, et al
    Induction of Apoptotic Death and Cell Cycle Arrest in HeLa Cells by Extracellular Factors of Breast Cancer Cells
    Asian Pac J Cancer Prev. 2018;19:3307-3316.
    Abstract    

    Abstract available

  116. STERBENC A, Maver PJ, Poljak M
    Recent advances in prophylactic human papillomavirus (HPV) vaccination: a review of key literature published between September 2017 and September 2018.
    Acta Dermatovenerol Alp Pannonica Adriat. 2018;27:193-201.
    Abstract    

    Abstract available

  117. STEWART CJR, Crum CP, McCluggage WG, Park KJ, et al
    Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites.
    Int J Gynecol Pathol. 2019;38 Suppl 1:S75-S92.
    Abstract    

    Abstract available

  118. PERON M, Llewellyn A, Moe-Byrne T, Walker S, et al
    Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation.
    Health Technol Assess. 2018;22:1-260.
    Abstract    

    Abstract available

  119. FUSCO FM, Vichi F, Bisanzi S, Sani C, et al
    HPV infection and pre-neoplastic cervical lesions among 321 HIV+ women in Florence, Italy, 2006-2016: prevalence and associated factors.
    New Microbiol. 2018;41:268-273.
    Abstract    

    Abstract available

  120. NKWABONG E, Laure Bessi Badjan I, Sando Z
    Pap smear accuracy for the diagnosis of cervical precancerous lesions.
    Trop Doct. 2019;49:34-39.
    Abstract    

    Abstract available

  121. CHINN Z, Stoler MH, Mills AM
    PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.
    Histopathology. 2019;74:256-268.
    Abstract    

    Abstract available

  122. PANTANO N, Hunt B, Schwarz RA, Parra S, et al
    Is Proflavine Exposure Associated with Disease Progression in Women with Cervical Dysplasia? A Brief Report.
    Photochem Photobiol. 2018;94:1308-1313.
    Abstract    

    Abstract available

  123. ONODERA K, Hatakenaka M, Yama N, Onodera M, et al
    Repeatability analysis of ADC histogram metrics of the uterus.
    Acta Radiol. 2019;60:526-534.
    Abstract    

    Abstract available

  124. MANCINI F, Vescio F, Mochi S, Accardi L, et al
    HPV and Chlamydia trachomatis coinfection in women with Pap smear abnormality: baseline data of the HPV Pathogen ISS study.
    Infez Med. 2018;26:139-144.
    Abstract    

    Abstract available

  125. NEVES F, Aldinhas P, Sousa R, Sa L, et al
    Letter to the Editor: Radical Vaginal Trachelectomy - 9-Year Experience of the IPO Coimbra.
    Acta Med Port. 2018;31:291-292.
    Abstract    



  126. SACRISTAN C, Ahmad MUD, Keller J, Fermie J, et al
    Dynamic kinetochore size regulation promotes microtubule capture and chromosome biorientation in mitosis.
    Nat Cell Biol. 2018;20:800-810.
    Abstract    

    Abstract available

  127. NAS H, Bowe D, Soubani AO
    An unusual complication after placement of an inferior vena cava filter via right internal jugular vein access.
    J Vasc Access. 2019;20:102-104.
    Abstract    

    Abstract available

  128. ISLAMI F, Fedewa SA, Jemal A
    Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
    Prev Med. 2019 Apr 16. pii: S0091-7435(19)30134.
    Abstract    

    Abstract available

  129. FU W, Hou G, Huang D
    [Long non-coding RNA and cervical cancer].
    Sheng Wu Gong Cheng Xue Bao. 2019;35:598-606.
    Abstract    

    Abstract available

  130. MAO Y, Dong L, Zheng Y, Dong J, et al
    Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature.
    Front Genet. 2019;10:284.
    Abstract    

    Abstract available

  131. DASHOTTAR S, Preeth Pany T, Lohia N
    Role of apparent diffusion coefficient as a biomarker in the evaluation of cervical cancer.
    Indian J Radiol Imaging. 2019;29:25-32.
    Abstract    

    Abstract available

  132. NEVIN PE, Garcia PJ, Blas MM, Rao D, et al
    Inequities in cervical cancer care in indigenous Peruvian women.
    Lancet Glob Health. 2019;7:e556-e557.
    Abstract    



  133. ISHIMARU N, Kanzawa Y, Seto H, Kinami S, et al
    Syphilitic Cervicitis with Cervical Cancer Presenting as Oropharyngeal Syphilis: A Case Report.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2426.
    Abstract    

    Abstract available

  134. ZHU L, Wang C, Pang DW, Zhang ZL, et al
    Controlled Release of Therapeutic Agents with NIR Laser for Synergistic Photo-Chemotherapy towards Cervical Cancer.
    Anal Chem. 2019 Apr 17. doi: 10.1021/acs.analchem.8b05982.
    Abstract    

    Abstract available

  135. LIEBER M, Afzal O, Shaia K, Mandelberger A, et al
    Cervical Cancer Screening in HIV-Positive Farmers in South Africa: Mixed-Method Assessment.
    Ann Glob Health. 2019;85.
    Abstract    

    Abstract available

  136. SOHRABI A
    Response to Letter to Editor "JAK2 V617F Mutation in Cervical Cancer Related to HPV & STIs" by Stephen E. Langabeer.
    J Cancer Prev. 2019;24:61-62.
    Abstract    



  137. LANGABEER SE
    "JAK2 V617F Mutation in Cervical Cancer Related to HPV & STIs" - Letter.
    J Cancer Prev. 2019;24:59-60.
    Abstract    



  138. PAUL S, Singh M
    RFCM3: Computational Method for Identification of miRNA-mRNA Regulatory Modules in Cervical Cancer.
    IEEE/ACM Trans Comput Biol Bioinform. 2019.
    Abstract    

    Abstract available

  139. CASTILLO-BAUTISTA CM, Torres-Tapia LW, Lagunas-Martinez A, Contreras-Ochoa CO, et al
    Secundiflorol G isolated from Aeschynomene fascicularis, a Mayan medicinal plant, induces apoptosis in cervical cancer cells.
    Nat Prod Res. 2019 Apr 16:1-3. doi: 10.1080/14786419.2019.1601092.
    Abstract    

    Abstract available

  140. SU M, Gong XJ, Zhou X
    [Research progress in mechanism of traditional Chinese medicine active ingredients against cervical cancer].
    Zhongguo Zhong Yao Za Zhi. 2019;44:675-684.
    Abstract    

    Abstract available

  141. TETEH DK, Dawkins-Moultin L, Robinson C, LaGroon V, et al
    Use of community forums to increase knowledge of HPV and cervical cancer in African American communities.
    J Community Health. 2019 Apr 15. pii: 10.1007/s10900-019-00665.
    Abstract    

    Abstract available

  142. ZHANG Y, Yang Y, Liu R, Meng Y, et al
    Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1.
    Exp Ther Med. 2019;17:4032-4038.
    Abstract    

    Abstract available

  143. SHI X, Xu M, Luo K, Huang W, et al
    Anticancer activity of bergenin against cervical cancer cells involves apoptosis, cell cycle arrest, inhibition of cell migration and the STAT3 signalling pathway.
    Exp Ther Med. 2019;17:3525-3529.
    Abstract    

    Abstract available

  144. CHEN Y, Xu Y, Wu D, Li Z, et al
    Survey of cervical cancer and precancerous lesion prevention knowledge within community health service centers in Shanghai, China.
    Medicine (Baltimore). 2019;98:e15002.
    Abstract    

    Abstract available

  145. ZHONG X, Li J, Zhang L, Lu B, et al
    Characterization of Insufficiency Fracture and Bone Metastasis After Radiotherapy in Patients With Cervical Cancer Detected by Bone Scan: Role of Magnetic Resonance Imaging.
    Front Oncol. 2019;9:183.
    Abstract    

    Abstract available

  146. FABRI VA, Queiroz ACM, Mantoan H, Sanches SM, et al
    The Impact of Addition of Consolidation Chemotherapy to Standard Cisplatin-Based Chemoradiotherapy in Uterine Cervical Cancer: Matter of Distant Relapse.
    J Oncol. 2019;2019:1217838.
    Abstract    

    Abstract available

  147. ZHOU Z, Yang H, Yang L, Yao Y, et al
    Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.
    Infect Genet Evol. 2019;73:13-20.
    Abstract    

    Abstract available

  148. CAPOROSSI A, Olicard C, Seigneurin A, Garnier A, et al
    [Interval between two smear tests for cervical cancer screening and characteristics of women with a short interval: Study in the department of Isere].
    Rev Epidemiol Sante Publique. 2019 Apr 10. pii: S0398-7620(19)30297.
    Abstract    

    Abstract available

  149. ZHOU C, Taylor S, Tugwood J, Simpson K, et al
    Dynamics of circulating VEGF-A predict benefit from anti-angiogenic cediranib in metastatic or recurrent cervical cancer patients.
    Br J Clin Pharmacol. 2019 Apr 13. doi: 10.1111/bcp.13965.
    Abstract    

    Abstract available

  150. GU KW, Kim CK, Choi CH, Yoon YC, et al
    Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Eur Radiol. 2019 Apr 12. pii: 10.1007/s00330-019-06204.
    Abstract    

    Abstract available

  151. GAO ZY, Liu X, Yang FM, Liu L, et al
    Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: A systematic review and meta-analysis.
    Biosci Rep. 2019 Apr 12. pii: BSR20182328. doi: 10.1042/BSR20182328.
    Abstract    

    Abstract available

  152. DE POKOMANDY A, Burchell AN, Salters K, Ding E, et al
    Cervical cancer screening among women living with HIV: a cross-sectional study using the baseline questionnaire data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS).
    CMAJ Open. 2019;7:E217-E226.
    Abstract    

    Abstract available

  153. XI C, Wang L, Yu J, Ye H, et al
    Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer.
    Biochem Biophys Res Commun. 2019 Apr 10. pii: S0006-291X(19)30636.
    Abstract    

    Abstract available

  154. PALMER T, Wallace L, Pollock KG, Cuschieri K, et al
    Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.
    BMJ. 2019;365:l1161.
    Abstract    

    Abstract available

  155. LEI J, Andrae B, Ploner A, Lagheden C, et al
    Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    BMJ. 2019;365:l1207.
    Abstract    

    Abstract available

  156. LEE J, Carvallo M, Lee E, Chung J, et al
    Affective and Cognitive Attitudes on Cervical Health Behaviors Among Asian American Women.
    Fam Community Health. 2019;42:123-132.
    Abstract    

    Abstract available

  157. MAO Y, Fu Z, Dong L, Zheng Y, et al
    Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
    DNA Cell Biol. 2019;38:322-332.
    Abstract    

    Abstract available

  158. NAKAJIMA T, Hatta H, Nishida T, Minamisaka T, et al
    Superficial spread of cervical squamous cell carcinoma to the upper genital tract and dissemination to the omentum.
    Pathol Int. 2019;69:119-121.
    Abstract    



  159. LI H, Zhang W, Yan M, Qiu J, et al
    Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/beta-catenin signaling.
    J Exp Clin Cancer Res. 2019;38:33.
    Abstract    

    Abstract available

  160. WISE J
    DIY smear tests: are they the answer to falling cervical screening rates?
    BMJ. 2019;364:l361.
    Abstract    



  161. PYO JS, Kang G, Yoon HK, Kim HJ, et al
    Diagnostic Test Accuracy Review of Cytology for Squamous Intraepithelial Lesion and Squamous Cell Carcinoma of Uterine Cervix.
    J Korean Med Sci. 2019;34:e16.
    Abstract    

    Abstract available

  162. ZHANG P, Zhang Y, Liu K, Liu B, et al
    Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway.
    Cell Prolif. 2019;52:e12543.
    Abstract    

    Abstract available

  163. ABAK B, Gole P, Dongre A, Kharkar V, et al
    Syringocystadenoma papilliferum of the cervix presenting as vulvar growth in an adolescent girl.
    Clin Exp Dermatol. 2019;44:58-61.
    Abstract    

    Abstract available

  164. BONTE AS, Luyckx A, Wyckmans L, Trinh XB, et al
    Quality indicators for the management of endometrial, cervical and ovarian cancer.
    Eur J Surg Oncol. 2019;45:528-537.
    Abstract    

    Abstract available

  165. PIROG EC, Park KJ, Kiyokawa T, Zhang X, et al
    Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances.
    Adv Anat Pathol. 2019;26:1-12.
    Abstract    

    Abstract available

  166. SPRIGGS CC, Blanco LZ, Maniar KP, Laimins LA, et al
    Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression.
    Int J Gynecol Pathol. 2019;38:1-10.
    Abstract    

    Abstract available

  167. HUNG CY, Lee CH, Chiou HL, Lin CL, et al
    Praeruptorin-B Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Cell Invasion by Targeting AKT/NF-kappaB via Matrix Metalloproteinase-2/-9 Expression in Human Cervical Cancer Cells.
    Cell Physiol Biochem. 2019;52:1255-1266.
    Abstract    

    Abstract available

  168. ZHANG Y, Zhang L
    Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.
    J Cell Biochem. 2019 Apr 26. doi: 10.1002/jcb.28806.
    Abstract    

    Abstract available

  169. LI Y, Wang H, Huang H
    Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer.
    Biochem Biophys Res Commun. 2019 Apr 22. pii: S0006-291X(19)30744.
    Abstract    

    Abstract available

  170. ABAMECHA F, Tena A, Kiros G
    Psychographic predictors of intention to use cervical cancer screening services among women attending maternal and child health services in Southern Ethiopia: the theory of planned behavior (TPB) perspective.
    BMC Public Health. 2019;19:434.
    Abstract    

    Abstract available

  171. YILDIRIM BA, Guler OC, Kose F, Onal C, et al
    The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy.
    J Obstet Gynaecol. 2019 Apr 25:1-7. doi: 10.1080/01443615.2019.1586852.
    Abstract    

    Abstract available

  172. GAMBOA O, Gonzalez M, Bonilla J, Luna J, et al
    Visual techniques for cervical cancer screening in Colombia.
    Biomedica. 2019;39:65-74.
    Abstract    

    Abstract available

  173. OCHOA CY, Murphy ST, Frank LB, Baezconde-Garbanati LA, et al
    Using a Culturally Tailored Narrative to Increase Cervical Cancer Detection Among Spanish-Speaking Mexican-American Women.
    J Cancer Educ. 2019 Apr 24. pii: 10.1007/s13187-019-01521.
    Abstract    

    Abstract available

  174. HU L, Wang Y, Chen Z, Fu L, et al
    Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
    Oxid Med Cell Longev. 2019;2019:9675450.
    Abstract    

    Abstract available

  175. TSATSOU I, Parpa E, Tsilika E, Katsaragakis S, et al
    A systematic review of sexuality and depression of cervical cancer patients.
    J Sex Marital Ther. 2019 Apr 24:1-35. doi: 10.1080/0092623X.2019.1610125.
    Abstract    

    Abstract available

  176. SHI F, Su J, Liu Z, Wang J, et al
    miR-144 reverses cisplatin resistance in cervical cancer via targeting LHX2.
    J Cell Biochem. 2019 Apr 24. doi: 10.1002/jcb.28763.
    Abstract    

    Abstract available

  177. WU J, Zhao Y, Li F, Qiao B, et al
    MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer.
    J Physiol Biochem. 2019 Apr 23. pii: 10.1007/s13105-019-00681.
    Abstract    

    Abstract available

  178. LEE J, Kim CK, Gu KW, Park W, et al
    Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Eur Radiol. 2019 Apr 23. pii: 10.1007/s00330-019-06198.
    Abstract    

    Abstract available

  179. SHYAMSIVAPPAN S, Vivek R, Saravanan A, Arasakumar T, et al
    Synthesis and X-ray study of dispiro 8-nitroquinolone analogues and their cytotoxic properties against human cervical cancer HeLa cells.
    Medchemcomm. 2019;10:439-449.
    Abstract    

    Abstract available

  180. LIONTOS M, Kyriazoglou A, Dimitriadis I, Dimopoulos MA, et al
    Systemic therapy in cervical cancer: 30 years in review.
    Crit Rev Oncol Hematol. 2019;137:9-17.
    Abstract    

    Abstract available

  181. TAPERA O, Kadzatsa W, Nyakabau AM, Mavhu W, et al
    Sociodemographic inequities in cervical cancer screening, treatment and care amongst women aged at least 25 years: evidence from surveys in Harare, Zimbabwe.
    BMC Public Health. 2019;19:428.
    Abstract    

    Abstract available

  182. ZHONG ML, Liang MR, Jiang W, Wang YN, et al
    [The indication and surgery scope for laparoscopic extraperitoneal lymphadenectomy in locally advanced cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2019;41:303-308.
    Abstract    

    Abstract available

  183. MCDONNELL AM, Pyles HM, Diaz-Cruz ES, Barton CE, et al
    Enoxacin and Epigallocatechin Gallate (EGCG) Act Synergistically to Inhibit the Growth of Cervical Cancer Cells in Culture.
    Molecules. 2019;24.
    Abstract    

    Abstract available

  184. RUBINSAK LA, Terplan M, Martin CE, Fields EC, et al
    Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer.
    Gynecol Oncol Rep. 2019;28:116-119.
    Abstract    

    Abstract available

  185. LI N, Piao J, Wang X, Kim KY, et al
    Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis.
    Cancer Res Treat. 2019 Apr 19. pii: crt.2018.544. doi: 10.4143/crt.2018.
    Abstract    

    Abstract available

  186. XU J, Wang H, Wang H, Chen Q, et al
    The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.
    Hereditas. 2019;156:11.
    Abstract    

    Abstract available

  187. HAN L, Yan P, Yao L, Liu R, et al
    Safety and effectiveness of robotic hysterectomy versus conventional laparoscopic hysterectomy in patients with cervical cancer in China.
    Arch Gynecol Obstet. 2019 Apr 21. pii: 10.1007/s00404-019-05148.
    Abstract    

    Abstract available

  188. ZHAO Y, Hu J, Xiang J, Li W, et al
    Hidden blood loss and its risk factors in patients undergoing laparoscopy and laparotomy for cervical cancer management.
    Arch Gynecol Obstet. 2019 Apr 21. pii: 10.1007/s00404-019-05162.
    Abstract    

    Abstract available

  189. VERCELLINO GF, Erdemoglu E, Lichtenberg P, Muallem MZ, et al
    A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer.
    Arch Gynecol Obstet. 2019 Apr 21. pii: 10.1007/s00404-019-05164.
    Abstract    

    Abstract available

  190. XIE Z, Wei Y, Xu J, Lei J, et al
    Alkaloids from Piper nigrum synergistically enhanced the effect of paclitaxel against paclitaxel-resistant cervical cancer cells through the downregulation of Mcl-1.
    J Agric Food Chem. 2019 Apr 22. doi: 10.1021/acs.jafc.9b01320.
    Abstract    

    Abstract available

  191. SRINIVASAN R
    Cervical cancer genomics: an initial step towards personalized approach to therapy.
    EBioMedicine. 2019 Apr 17. pii: S2352-3964(19)30264.
    Abstract    



  192. HALLOWELL BD, Endeshaw M, McKenna MT, Senkomago V, et al
    Cervical Cancer Death Rates Among U.S.- and Foreign-Born Women: U.S., 2005-2014.
    Am J Prev Med. 2019 Apr 12. pii: S0749-3797(19)30040.
    Abstract    

    Abstract available

  193. WANG T, Gao T, Yang J, Yan X, et al
    Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging.
    Eur J Radiol. 2019;114:128-135.
    Abstract    

    Abstract available

  194. AJORLOO M, Alamdary A, Soleimanjahi H, El Boulani A, et al
    Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer.
    Microb Pathog. 2019;132:20-25.
    Abstract    

    Abstract available

  195. MCCLUNG NM, Gargano JW, Park IU, Whitney E, et al
    Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016.
    MMWR Morb Mortal Wkly Rep. 2019;68:337-343.
    Abstract    

    Abstract available

  196. YU YY, Zhang R, Dong RT, Hu QY, et al
    Feasibility of an ADC-based radiomics model for predicting pelvic lymph node metastases in patients with stage IB-IIA cervical squamous cell carcinoma.
    Br J Radiol. 2019;92:20180986.
    Abstract    

    Abstract available

  197. BALDAUF JJ
    [J.-J. Baldauf in reply to the correspondence by P. Vassilakos and P. Petignat on the article entitled: "Organized cervical screeening at last in France!!". Gynecol Obstet Fertil Senol 2019;47:1-2].
    Gynecol Obstet Fertil Senol. 2019;47:392.
    Abstract    



  198. HABEEB A, Habeeb H
    Large cell neuroendocrine carcinoma of the uterine cervix.
    BMJ Case Rep. 2019;12.
    Abstract    

    Abstract available

  199. KUKIMOTO I
    [Human Papillomavirus Carcinogenesis Mediated by APOBEC Mutagenesis].
    Yakugaku Zasshi. 2019;139:75-79.
    Abstract    

    Abstract available

  200. ABI JAOUDE J, Khair D, Dagher H, Saad H, et al
    Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study.
    Vaccine. 2018;36:7562-7567.
    Abstract    

    Abstract available

  201. NAPOLITANO F, Gualdieri L, Santagati G, Angelillo IF, et al
    Knowledge and attitudes toward HPV infection and vaccination among immigrants and refugees in Italy.
    Vaccine. 2018;36:7536-7541.
    Abstract    

    Abstract available

  202. CALO WA, Gilkey MB, Malo TL, Robichaud M, et al
    A content analysis of HPV vaccination messages available online.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31419.
    Abstract    

    Abstract available

  203. SPIEGEL DY, Chino F, Moss H, Havrilesky LJ, et al
    Changes in insurance coverage for cancer patients receiving brachytherapy before and after enactment of the Affordable Care Act.
    Brachytherapy. 2019;18:115-121.
    Abstract    

    Abstract available

  204. DE BRUIJN AM, Adriaansens SJH, Smink M, Venmans A, et al
    Uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and Safety.
    Cardiovasc Intervent Radiol. 2019;42:371-380.
    Abstract    

    Abstract available

  205. CROWELL EF, Bazin C, Saunier F, Brixtel R, et al
    CytoProcessorTM: A New Cervical Cancer Screening System for Remote Diagnosis.
    Acta Cytol. 2019 Mar 28:1-9. doi: 10.1159/000497111.
    Abstract    

    Abstract available

  206. HORN J, Denecke A, Luyten A, Rothe B, et al
    Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany.
    Br J Cancer. 2019 Apr 16. pii: 10.1038/s41416-019-0453.
    Abstract    

    Abstract available

  207. PRINTZ C
    Cervical cancer self-sampling tests could improve access.
    Cancer. 2019;125:1583.
    Abstract    



  208. SHACHNER TR, Van Meter SE
    Metastatic melanoma of the uterine cervix diagnosed on cervical Pap smear: Case report and literature review.
    Diagn Cytopathol. 2018 Oct 24. doi: 10.1002/dc.24058.
    Abstract    

    Abstract available

  209. UREYEN I, Toptas T, Uysal A
    Is routine ECC necessary in patients with HPV16 and normal cytology?
    Diagn Cytopathol. 2018;46:1031-1035.
    Abstract    

    Abstract available

  210. MALLIK MK, Alramadhan B, Dashti H, Al-Shaheen A, et al
    Human papillomaviruses other than 16, 18 and 45 are the major high risk HPV genotypes amongst women with abnormal cervical smear cytology residing in Kuwait: Implications for future vaccination strategies.
    Diagn Cytopathol. 2018;46:1036-1039.
    Abstract    

    Abstract available

  211. NUNES RD, Cascaes M, Schneider IJC, Traebert J, et al
    Effects of using lubricant during the speculum examination for Pap smear collection.
    Diagn Cytopathol. 2018;46:1040-1044.
    Abstract    

    Abstract available

  212. AGENJO GONZALEZ M, Lampaya Nasarre B, Salazar F, Varillas D, et al
    Influence of intrauterine dispositive in human papillomavirus clearance.
    Eur J Obstet Gynecol Reprod Biol. 2018;232:65-69.
    Abstract    

    Abstract available

  213. LIN AJ, Ma S, Markovina S, Schwarz J, et al
    Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
    Gynecol Oncol. 2019 Mar 21. pii: S0090-8258(19)30297.
    Abstract    

    Abstract available

  214. BOGANI G, Chiappa V, Vinti D, Somigliana E, et al
    Long-term results of fertility-sparing treatment for early-stage cervical cancer.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30502.
    Abstract    

    Abstract available

  215. PIGNATA S, Scambia G, Lorusso D, De Giorgi U, et al
    The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
    Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30495.
    Abstract    

    Abstract available

  216. HALL MT, Smith MA, Lew JB, O'Hallahan J, et al
    The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Gynecol Oncol. 2019;152:472-479.
    Abstract    

    Abstract available

  217. SHEU J, Palileo A, Chen MY, Hoepner L, et al
    Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample.
    Gynecol Oncol. 2019;152:594-598.
    Abstract    

    Abstract available

  218. MA S, Wang J, Han Y, Guo F, et al
    Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Gynecol Oncol. 2019 Apr 18. pii: S0090-8258(19)30508.
    Abstract    

    Abstract available

  219. BALAYA V, Mathevet P, Magaud L, Bonsang-Kitzis H, et al
    Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30503.
    Abstract    

    Abstract available

  220. TIAN J, Geng Y, Lv D, Li P, et al
    Using plasma cell free DNA to monitor the chemo-radiotherapy course of cervical cancer.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32295.
    Abstract    

    Abstract available

  221. AMARO-FILHO SM, Gradissimo A, Usyk M, Moreira FCB, et al
    HPV73 a non-vaccine type causes cervical cancer.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32315.
    Abstract    

    Abstract available

  222. LEEMAN A, Del Pino M, Marimon L, Torne A, et al
    Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Int J Cancer. 2019;144:160-168.
    Abstract    

    Abstract available

  223. CHEN C, Zhang W, Liu P, Su G, et al
    Discrepancies between clinical staging and surgicopathologic findings in early-stage cervical cancer and prognostic significance.
    Int J Gynaecol Obstet. 2019 Mar 22. doi: 10.1002/ijgo.12807.
    Abstract    

    Abstract available

  224. SALCEDO MP, Lorenzoni C, Schmeler KM
    Working together to eliminate cervical cancer: a partnership across three countries "As mudancas no mundo sao criadas por nos".
    Int J Gynecol Cancer. 2019 Apr 3. pii: ijgc-2019-000372.
    Abstract    



  225. BAINS I, Choi YH, Soldan K, Jit M, et al
    Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England.
    Int J Gynecol Cancer. 2019 Apr 24. pii: ijgc-2018-000161.
    Abstract    

    Abstract available

  226. TAN LT, Potter R, Sturdza A, Fokdal L, et al
    Change in patterns of failure after image-guided brachytherapy for cervical cancer: analysis from the RetroEMBRACE study.
    Int J Radiat Oncol Biol Phys. 2019 Mar 30. pii: S0360-3016(19)30565.
    Abstract    

    Abstract available

  227. CHEUNG TH, Yim SF, Yu MY, Worley MJ Jr, et al
    Liquid biopsy of HPV DNA in cervical cancer.
    J Clin Virol. 2019;114:32-36.
    Abstract    

    Abstract available

  228. SHI C, Yang Y, Zhang L, Zhang T, et al
    Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
    Oncol Rep. 2019 Apr 3. doi: 10.3892/or.2019.7097.
    Abstract    

    Abstract available

  229. HO JC, Fang P, Cardenas CE, Mohamed ASR, et al
    Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
    Radiother Oncol. 2019;135:58-64.
    Abstract    

    Abstract available

  230. FISET S, Welch ML, Weiss J, Pintilie M, et al
    Repeatability and reproducibility of MRI-based radiomic features in cervical cancer.
    Radiother Oncol. 2019;135:107-114.
    Abstract    

    Abstract available

  231. NOMDEN CN, Potter R, de Leeuw AAC, Tanderup K, et al
    Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
    Radiother Oncol. 2019;134:185-190.
    Abstract    

    Abstract available

  232. ZHANG X, Lv Z, Lou H
    The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
    BMC Cancer. 2019;19:22.
    Abstract    

    Abstract available

  233. MIGNOT S, Ringa V, Vigoureux S, Zins M, et al
    Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study.
    BMC Cancer. 2019;19:317.
    Abstract    

    Abstract available

  234. WUJANTO C, Choo BA, Tan D, Ilancheran A, et al
    Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    BMC Cancer. 2019;19:385.
    Abstract    

    Abstract available

  235. GAGO J, Paolino M, Arrossi S
    Factors associated with low adherence to cervical cancer follow-up retest among HPV+/ cytology negative women: a study in programmatic context in a low-income population in Argentina.
    BMC Cancer. 2019;19:367.
    Abstract    

    Abstract available

  236. PANKAKOSKI M, Anttila A, Sarkeala T, Heinavaara S, et al
    Effectiveness of cervical cancer screening at age 65 - A register-based cohort study.
    PLoS One. 2019;14:e0214486.
    Abstract    

    Abstract available

  237. LI T, Zhou W, Li Y, Gan Y, et al
    MiR-4524b-5p/WTX/beta-catenin axis functions as a regulator of metastasis in cervical cancer.
    PLoS One. 2019;14:e0214822.
    Abstract    

    Abstract available

  238. LIN CK, Liu ST, Chang CC, Huang SM, et al
    Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells.
    PLoS One. 2019;14:e0214408.
    Abstract    

    Abstract available

  239. ABBAS-AGHABABAZADEH F, Li Q, Fridley BL
    Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing.
    PLoS One. 2018;13:e0206312.
    Abstract    

    Abstract available

  240. EBISCH RMF, Ketelaars PJW, van der Sanden WMH, Schmeink CE, et al
    Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
    PLoS One. 2018;13:e0206219.
    Abstract    

    Abstract available

  241. PARK S, Lee S, Kim J, Kim G, et al
    DeltaNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    PLoS One. 2019;14:e0214867.
    Abstract    

    Abstract available

  242. CAMPOS RG, Malacara Rosas A, Gutierrez Santillan E, Delgado Gutierrez M, et al
    Unusual prevalence of high-risk genotypes of human papillomavirus in a group of women with neoplastic lesions and cervical cancer from Central Mexico.
    PLoS One. 2019;14:e0215222.
    Abstract    

    Abstract available

  243. WANG W, Liu X, Meng Q, Zhang F, et al
    Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    PLoS One. 2019;14:e0214498.
    Abstract    

    Abstract available

  244. SHERMAN SM, Bartholomew K, Denison HJ, Patel H, et al
    Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand.
    PLoS One. 2018;13:e0197648.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;